跳至主要内容
临床试验/NCT00171431
NCT00171431终止3 期

The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)

Novartis Pharmaceuticals2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2004年11月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
20
试验地点
2
主要终点
To evaluate the effects of tegaserod on motility and small intestinal flow patterns after meal in female patients with IBS-C

研究概览

简要总结

Evaluation of the effect of tegaserod treatment on small intestinal motility and flow pattern in female IBS-C patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female 18 and older
  • IBS-C patients diagnosed on the basis of Rome II criteria
  • Ability to comply with the requirements of the entire study

排除标准

  • Evidence of structural abnormality of the gastrointestinal tract or disease/conditions.
  • Patients with previous gastrointestinal surgery other than appendectomy or cholecystectomy.
  • Evidence of cathartic colon or a history of laxative use, that in the investigator's opinion is consistent with severe laxative dependence such that the patient is likely to require or use laxatives during the study
  • Other protocol-defined inclusion/exclusion criteria may apply.

结局指标

主要结局

To evaluate the effects of tegaserod on motility and small intestinal flow patterns after meal in female patients with IBS-C

by using Multiple Intraluminal Impedance

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验